Skip to main content

Peer Review reports

From: Cancer Precision-Prevention trial of Metformin in adults with Li Fraumeni syndrome (MILI) undergoing yearly MRI surveillance: a randomised controlled trial protocol

Original Submission
7 Oct 2023 Submitted Original manuscript
18 Dec 2023 Reviewed Reviewer Report - Kirsty Loudon
10 Jan 2024 Author responded Author comments - Miriam Dixon-Zegeye
Resubmission - Version 2
10 Jan 2024 Submitted Manuscript version 2
Publishing
16 Jan 2024 Editorially accepted
3 Feb 2024 Article published 10.1186/s13063-024-07929-w

You can find further information about peer review here.

Back to article page